|
|||||
|
|
Resistance development over 144 weeks in treatment-naive patients receiving tenofovir disoproxil fumarate or stavudine with lamivudine and efavirenz in Study 903 |
|
| Authors: | Margot N A Lu B Cheng A Miller M D;Study Team |
| Institution: | Gilead Sciences, Inc., Foster City, CA 94404, USA. |
| Abstract: | |
| Keywords: | clinical trials K65R resistance tenofovir |
| 本文献已被 PubMed 等数据库收录！ | |